Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new compound may be a safer alternative to finasteride for prostate protection.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Anabolic steroid users may face higher risk of severe COVID-19.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Long-term treatment with buprenorphine/naloxone for opioid addiction may lead to secondary adrenal insufficiency.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Baricitinib works better than methotrexate for severe alopecia areata.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

These medications for BPH have known risks and may have new side effects.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.